CALGARY, AB, May 17, 2021 /CNW/ - adMare BioInnovations ("adMare") and AazeinTx Inc. ("AazeinTx") have closed a global exclusive licensing transaction for a promising acute asthma treatment.
Read MoreCALGARY, AB, May 17, 2021 /CNW/ - adMare BioInnovations ("adMare") and AazeinTx Inc. ("AazeinTx") have closed a global exclusive licensing transaction for a promising acute asthma treatment.
Read More